1.Transcriptional expression and promoter hypermethylation of RAS association domain family 1A gene in glioma
Yunxia GAO ; Ming GUAN ; Wanzhong ZHANG ; Yuan LU
Chinese Journal of Laboratory Medicine 2003;0(07):-
0. 05). In glioma, the expression level was higher in glioblastornathan in oligodendroglial tumors (P = 0. 011). While the frequency of promoter methylation of RASSFof RASSF1A gene was 39. 3% . It was not found the promoter methylation in normal brain tissues and U251 cell line. In 11 patients with the aberrant promoter methylation, five showed the gene inactivation (P = 0. 022). Conclusion Aberrant promoter methylation was found in glioma. Although the gene inactivation of RASSF1 A was not so common in glioma, its expression was lower in glioma than in normal brain tissues. Promoter methylation may contribute to the low level or loss of RASSFT A mRNA expression.
2.Transplantation of bone-marrow derived mesenchymal stem cells to treat rat retinal degeneration
Yuan GUAN ; Lu CUI ; Yalan WU ; Weiya LI ; Guotong XU
Chinese Journal of Ocular Fundus Diseases 2009;25(4):249-253
Objective To observe the effects of subretinal transplantation of rat mesenchymal stem cells (rMSCs) on Sodium Iodate (SI)-induced retinal degeneration.Methods One hundred and twenty Brown-Norway (BN) rats were divided into three groups including SI injection group,rMSCs transplantation group and normal control group,each with 40 rats.The retinal degeneration was induced by caudal vein injection of SI.The retinal pigment epithelium(RPE)and neural retinal were evaluated by ocular fundus photograph,fluorescein fundus angiography (FFA),electroretinogram (ERG) and histological approach,and TUNEL(terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling).CM-Dilprelabeled primary rMSCs were transplanted into the subretinal space of Sl-induced rats.The survival,integration,and differentiation of rMSCs were observed between 14 day to 60 day after the transplantation.Results The rat retinal function was gradually reduced afterl4 days of SI injection,with a time-dependent manner.After the RPE cells were damaged,the outer segments of photoreceptors became disrupted and shortened until karyopyknosis.The nuclear morphology and positive TUNEL labeling indicated that the death of photoreceptor cells was apoptosis.After rMSCs transplantation,CM-DiI labeled donor cells were observed to be scattered in the subretinal space and expressed RPE cell markers.Average amplitude of bwave and Ops (oscillation potential) in ERG improved 27.80%,59.38% respectively after rMSCs transplantation.Conclusions Transplanted rMSCs can survive in subretinal space and differentiate into RPE cells,thus cure SI- induced retinal degeneration.
3.Application of empowerment theory in the wound care of 13 patients with diabetic foot ulcer
Huijuan LI ; Xin QI ; Qian LU ; Geheng YUAN ; Hui GUAN ; Xiaohui GUO
Chinese Journal of Practical Nursing 2017;33(9):662-664
Objective To understand the effect of empowerment theory in wound care of patients with diabetic foot ulcer, to identify the problem, and to provide reference for the theory in clinical application. Methods Summarized the nursing interventions of 13 patients with diabetic foot of Strauss A classification using empowerment theory. Results All the wounds of 13 patients healed, the average total healing time were 70-273 (145.23 ± 68.87) days, and the median healing time were 111 days. The patients were followed up for 10-37 months without recurrence. Conclusions Using empowerment education in Strauss A classification diabetic foot patients Is feasible and worth promoting. However, to ensure patient safety, the process of application should be under close supervision.
4.An Emerging Method for Characterizing Microbial Ecology-T-Rflp Technique
Hong-Yuan WANG ; Xiao-Lu JIANG ; Hua-Shi GUAN ; Hai-Jin MU ;
Microbiology 1992;0(06):-
Terminal restriction fragment length polymorphism(T-RFLP) is a resent molecular approach that can assess subtle genetic differences between strains as well as provide insight into the structure and function of microbial communities. This method overcomes the confinement of conventional culture-dependent methods and has both high sensitivity and throughput making it ideal for comparative analyses. Though there is still no application in our country, more and more investigators are highlighting it. In this article, the fundamental principle of this technique is introduced. The recent application and the development of this technique are also summed up .
5.Diagnosis and treatment of glucagonoma
Xuefeng CAO ; Qinghai GUAN ; Xixiu WANG ; Yanmin LU ; Shuai YUAN ; Kun OU
Chinese Journal of Digestive Surgery 2014;13(10):819-821
Glucagonoma is a kind of neuroendocrine tumor of the pancreas,which is rarely seen in clinical practice.Glucagonoma is characterized by necrolytic migratou erythema (NME),diabetes,anemia and body weight loss,and NME is the most characteristic clinical manifestation.The most important laboratory basis of glucagonoma is the levels of fasting plasma glucagon.Various imaging examinations are helpful for the localization of the tumor.Operation is the main method for the treatment of glucagonoma.A patient with glucagonoma was admitted to the Affiliated Hospital of Binzhou Medical College in December 2013,and the experiences in the diagnosis and treatment of glucagonoma were shared based on the data of this patient.
6.Manifestations of contrast-enhanced ultrasound in different stage cervical cancer
Ling GUAN ; Qingming ZHANG ; Hong YUAN ; Liyun WANG ; Runjia DU ; Li ZHANG ; Yun LU
Chinese Journal of Ultrasonography 2010;19(6):514-516
Objective To summarize the manifestations of contrast-enhanced ultrasound in different stage cervical cancer.Methods Contrast-enhanced ultrasound using pulse inversion harmonic imaging and on time-intensity curve was undergone in 48 cases with pathologically diagnosed cervical cancer, data were analyzed to summarize the features of contrast enhancement.Results Lesion tissue was enhanced homogeneously or heterogeneously earlier than myometrium.Lesion exhibited earlier washout than that of myomerium in the later phase, while the peripheral area still remained hyper-enhancement.Lesion invasion and borderline could be determined in ultrasound clearly.Conclusions Contrast-enhanced ultrasound could accurately diagnose the stage of cervical cancer and lesion invasion.It may compensate for the shortcomings of conventional ultrasound in the diagnosis of cervical cancers and disease stage.
7.Hernsubanine E, a new hasubanan alkaloid from Stephania hernandifolia.
Nan ZHANG ; Li-Jia TANG ; Lu-Lu DENG ; Huan-Yu GUAN ; Jian-Xin ZHANG ; Xiao-Jiang HAO ; Yuan-Hu ZHANG
China Journal of Chinese Materia Medica 2014;39(6):1020-1023
A new hasubanan alkaloid, hernsubanine E (1), as well as two known compounds p-hydroxybenzaldehyde (2) and (-)-syringaresinol (3) have been isolated from the whole plants of Stephania hernandifolia by various column chromatographic methods. Their structures were identified by physicochemical properties and spectral analyses. Compounds 2 and 3 were isolated from the genus of Stephania for the first time.
Alkaloids
;
chemistry
;
Heterocyclic Compounds, 4 or More Rings
;
chemistry
;
isolation & purification
;
Stephania
;
chemistry
8.Studies on structure characteristic of polysaccharide P1A from Dicliptera chinensis.
Yu-yuan HE ; Lu-wei XIE ; Guan-feng DU ; Jiang-cheng ZHAN ; Yong-qin YIN ; Zhi-bin SHEN
China Journal of Chinese Materia Medica 2015;40(8):1489-1492
The chemical structures of P1 A was identified by complete acid hydrolysis, partial acid hydrolysis, periodate oxidation-Smith degradation, methylation analysis, IR and NMR. The results showed that P1 A had a backbone consisting rhamnose, mannose, glucose and galactose. The side chain possessed arabinose and xylose. 1-->, 1-->6 and non-reducing terminal linkages existed in polysaccharide P1A, but there are doubling amount of 1-->2 and 1-->4 linkages. Oxidable linkage of P1 A accounted for 45%, and inoxidable linkage of P1A accounted for 55%. Mannose, glucose and galactose were mainly linked by 1-->2 linkage. Rhamnose, arabinose and xylose were mainly linked by 1-->2 and 1-->4 linkages. PlA contained beta-Glc(1,6)-,beta-Gal(1,3)-,beta-Man(1,4)-beta-Rha,-Glc(1,4)-, Glc(1)-,-Gal(1,4)- and Man(1)-.
Acanthaceae
;
chemistry
;
Drugs, Chinese Herbal
;
chemistry
;
Magnetic Resonance Spectroscopy
;
Molecular Structure
;
Molecular Weight
;
Polysaccharides
;
chemistry
9.Analysis of the Relationship Between Era and YggG in E.coli by Double-promoter Expression Vector pDH2-YggG-P_(tac)-Era
Yong HUANG ; Xiao-Nan ZHANG ; Bin ZHANG ; Tao WANG ; Li WANG ; Lu-Yuan GUAN ; Nan-Chun CHEN ; Su-Min CHEN ;
China Biotechnology 2006;0(03):-
yggG, a Era-binding protein gene, was isolated and cloned from the E.coli genomic DNA library. Previous studies indicated that the product of yggG gene, YggG294(amino acids 1-294), strongly inhibited the growth of host bacteria and caused the death of bacteria cells. To elucidate whether Era is related to the death of bacterial cells expressed YggG294,A double promoter expression vector that can express YggG294 and Era proteins controllably in cells was constructed. Using this vector to express YggG294 and Era protein in the same E.coli cells, then analyzed the relation between YggG294 and Era. The results showed that the ratio of Era proteins to total proteins increased with the increase of induction time in E.coli cells without YggG294 expression and with little YggG294 expression;the ratio of Era proteins to total proteins seemed to be a constant level in E.coli cells overexpressing YggG294;but we could not detect any Era hydrolyzate in E.coli cells overexpressed YggG294 could not be detected. The results also showed that pre-expression of Era protein did not produce any effect on the growth inhibition of E.coli cells caused by YggG294. These results indicate that YggG294 can not hydrolyze Era protein in E.coli cells, and that YggG-Era interaction is not associated with the death of bacteria expressed YggG294. It is thus reasonable to draw a conclusion that Era is not associated with the growth inhibition of E.coli cells caused by YggG294. YggG294 inhibits the growth of bacteria by other way.
10.Efficacy of recombinant human thrombopoietin combined with high-dose dexamethasone in the treatment of refractory immune thrombocytopenia in children.
Yuan-Yuan LU ; Na GUAN ; Qing-Hong MENG ; Ming-Lei LI ; Yun-Yun LIU ; Ying WANG
Chinese Journal of Contemporary Pediatrics 2018;20(7):534-537
OBJECTIVETo explore the efficacy and safety of recombinant human thrombopoietin (rhTPO) combined with high-dose dexamethasone (DXM) in the treatment of children with refractory immune thrombocytopenic purpura (ITP).
METHODSFifty-eight ITP children who had failed first-line therapy were randomly divided into two groups: DXM treatment (n=27) and rhTPO + DXM treatment (n=31). The DXM treatment group received two continuous cycles of DXM treatment; in each cycle, patients received high-dose DXM (0.6 mg/kg daily) by intravenous drip for 4 days every 28 days. The rhTPO group received subcutaneous injection of rhTPO (300 U/kg daily) for 14 days additional to DXM treatment. The overall response rate (marked response rate + slight response rate) and adverse reactions were evaluated after 3, 7, and 14 days and 1, 2, and 3 months of treatment.
RESULTSAfter 7 and 14 days and 1 month of treatment, the rhTPO + DXM treatment group had a significantly higher marked response rate and a significantly higher overall response rate than the DXM treatment group (P<0.05). After 2 months of treatment, the rhTPO + DXM treatment group had a significantly higher overall response rate than the DXM group (P<0.05). One patient in the DXM treatment group had liver damage during the first week of treatment. There was no hypertension, fever, rash, allergy, or weakness in the two groups.
CONCLUSIONSrhTPO combined with high-dose DXM is an effective and safe approach for treating refractory ITP.
Child ; Child, Preschool ; Dexamethasone ; administration & dosage ; adverse effects ; Drug Therapy, Combination ; Female ; Humans ; Infant ; Male ; Purpura, Thrombocytopenic, Idiopathic ; drug therapy ; Recombinant Proteins ; administration & dosage ; Thrombopoietin ; administration & dosage ; adverse effects ; Treatment Outcome